Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11052088 Kinase inhibitor salts, and compositions thereof

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+99 characters)
Article

Patent abstract

The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.

Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1105208800
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 21 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110520880
Date of Patent
July 6, 2021
0
Patent Application Number
171677190
Date Filed
February 4, 2021
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110520880
Patent Citations
‌
US Patent 10000470 Method for preparing nilotinib
0
‌
US Patent 10016423 Solid forms of nilotinib hydrochloride
0
‌
US Patent 10023566 Dasatinib salts
0
‌
US Patent 10034873 C-met modulator pharmaceutical compositions
0
‌
US Patent 10039757 C-Met modulator pharmaceutical compositions
0
‌
US Patent 10052307 Micellar nanocomplex
0
‌
US Patent 10076520 Use of tyrosine kinase inhibitor in cancer treatment
0
‌
US Patent 10080723 Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
0
‌
US Patent 10105323 Pharmaceutical dosage form for immediate release of an indolinone derivative
0
‌
US Patent 10117881 Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
0
‌
US Patent 10138221 Salts of nilotinib and polymorphs thereof
0
‌
US Patent 10143683 Pharmaceutical compositions
0
‌
US Patent 10150733 Amidoheteroaryl aroyl hydrazide ethynes
0
‌
US Patent 10154990 Medicaments for the treatment or prevention of fibrotic diseases
0
‌
US Patent 10238602 Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
0
‌
US Patent 10253371 Method of treating leukemia based on gene expression of clock genes
0
‌
US Patent 10258691 Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
0
‌
US Patent 10260097 Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
0
‌
US Patent 10272102 Hydroxyalkyl starch for the treatment of hematological neoplasms
0
‌
US Patent 10314830 Pharmaceutical compositions
0
‌
US Patent 10280153 Process for the preparation of pure nilotinib and its salt
0
‌
US Patent 10301282 Polymorphic form X of nilotinib dihydrochloride hydrate
0
‌
US Patent 10301302 Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof
0
‌
US Patent 10349884 Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
0
‌
US Patent 10357458 Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
0
‌
US Patent 10392351 Method for preparing nilotinib intermediate
0
‌
US Patent 10449193 Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
0
‌
US Patent 10532045 Liposomal mitigation of drug-induced inhibition of the cardiac I
0
Patent Primary Examiner
‌
Jared Barsky
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022

Find more entities like US Patent 11052088 Kinase inhibitor salts, and compositions thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.